Alnylam Partners with Ironwood to Make Doctors More Aware of Givosiran’s Potential
News
Alnylam Pharmaceuticals and Ironwood Pharmaceuticals are joining forces to better inform healthcare professionals about givosiran, Alnylam’s potential therapeutic for acute hepatic porphyria (AHP). Givosiran (also known as ALN-AS1) is an RNA-based ... Read more